Cozaar XQ Re-examination Study (MK-0954-349)

Organon logo

Organon

Status

Completed

Conditions

Hypertension

Treatments

Drug: amlodipine/losartan

Study type

Observational

Funder types

Industry

Identifiers

NCT01041807
0954-349
2009_004 (Other Identifier)

Details and patient eligibility

About

This survey is conducted for preparing application material for re-examination under the Pharmaceutical Affairs Law and its Enforcement Regulation; its aim is to reconfirm the clinical usefulness of COZAAR XQ through collecting the safety and efficacy information according to the Re-examination Regulation for New Drugs.

Enrollment

669 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participant with essential hypertension
  • Participant who is treated with COZAAR XQ within local label for the first time

Exclusion criteria

  • Participant who is treated with COZAAR XQ before contract and out of enrollment period
  • Participant who has a contraindication to COZAAR XQ according to the local label

Trial design

669 participants in 1 patient group

All participants
Description:
Participants with hypertension treated with amlodipine/losartan(Cozaar XQ)
Treatment:
Drug: amlodipine/losartan

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems